Mammographic density is a potential predictive marker of pathological response after neoadjuvant chemotherapy in breast cancer

Our aim is to study if mammographic density (MD) prior to neoadjuvant chemotherapy is a predictive factor in accomplishing a pathological complete response (pCR) in neoadjuvant-treated breast cancer patients.